XLV vs TDNA
YTDYear to date
Level
Past year
Level
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV4481.3× more
2–0XLV wins
XLV and TDNA · year-to-date · as of Nov 4, 2026 · AUM not scored
TDNA vs S&P 500
YTD$24.66 · +1.2% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+1.2%−0.4%—————−3.3%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
T. Rowe Price TDNA and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
TDNA’s Holdings
TodayARGX5.1%KYMR4.8%KOD2.8%INSM2.6%UTHR2.5%VRTX2.5%NTRA2.3%MRNA2.2%RVMD2.2%BBIO2.1%PCVX2.1%SYRE2.0%PRAX1.9%DNTH1.8%RYTM1.8%CYTK1.8%ALKS1.8%MIRM1.7%ARWR1.6%CGON1.6%TNGX1.6%Other
BiotechnologyMedical - DiagnosticsDrug Manufacturers - Specialty
T. Rowe Price TDNA · 0 holdings · tile size = share of the fund · as of Nov 3, 2026
All 39 Health Care ETFs
Today| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.4% | −0.3% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.6% | −0.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +27.2% | +1.9% | $10.5B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +19.8% | −0.4% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +16.0% | −0.5% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −8.9% | −0.1% | $3.9B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.7% | −0.2% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +70.9% | +2.5% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.9% | −0.2% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.7% | +0.7% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.5% | −0.7% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +33.8% | 0.0% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +21.8% | +0.2% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.0% | −0.5% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +24.5% | −0.3% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +35.0% | +0.4% | $525M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 4, 2026
TDNA Payouts by Year
TodayTDNA pays no distribution.
TDNA’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −0.3% | +20.4% | +29.7% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −0.1% | +19.6% | +28.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +1.9% | +27.2% | +38.1% | $10.5B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.4% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | −0.5% | +16.0% | +24.7% | $4.6B | |
| 6 | TDNA | T. Rowe Price Biotech ETFThis fund | 0.55% | — | +1.2% | new | new | $11.0M |
#28 cheapest of 39 · sorted by assetsOpen the Sectors table →
TDNA and its peer group · total return · as of Nov 4, 2026
Cards for This View
TDNA’s Top 10 Holdings
Today29.1%of TDNA sits in these 10
T. Rowe Price TDNA · weight in the fund · as of Nov 3, 2026
TDNA’s Holdings
TodayARGX5.1%KYMR4.8%KOD2.8%INSM2.6%UTHR2.5%VRTX2.5%NTRA2.3%MRNA2.2%RVMD2.2%BBIO2.1%PCVX2.1%SYRE2.0%PRAX1.9%DNTH1.8%RYTM1.8%CYTK1.8%ALKS1.8%MIRM1.7%ARWR1.6%CGON1.6%TNGX1.6%Other
BiotechnologyMedical - DiagnosticsDrug Manufacturers - Specialty
T. Rowe Price TDNA · 0 holdings · tile size = share of the fund · as of Nov 3, 2026
TDNA vs Peer Average
YTDTDNAAvsBPeer average
1D+1.2%+0.6%
1M−0.4%+4.0%
3M[…]+6.1%
YTD[…]+21.0%
1Y[…]+29.0%
3Y[…]+81.2%
5Y[…]+28.9%
1–1level
38 Health care peers · each row scaled to its leader